CHARLES W III NEWHALL
CIK 1005544 · last filed 2026-02-25
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$406.43M
Companies
16
Total Filings
124
Lifetime Open-Market Net
-$8.76M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| SUPN | Director | 6,365,369 | $44.41 | $282.69M | $20.00M | 32 | 2026-02-25 |
| Vitae Pharmaceuticals, Inc (VTAE) Delisted | Director | 289 | — | — | $0 | 4 | 2015-07-10 |
| WDAY | 10%+ Owner | — | $130.80 | — | $0 | 1 | 2012-10-18 |
| FUSION-IO, INC. (FIO) Delisted | 10%+ Owner | 9,039,445 | — | — | -$40.98M | 15 | 2012-09-06 |
| HYPERION THERAPEUTICS INC (HPTX) Delisted | 10%+ Owner | 1,639,218 | — | — | $5.00M | 1 | 2012-08-02 |
| INNERWORKINGS INC (INWK) Delisted | 10%+ Owner | 4,529,190 | — | — | -$12.62M | 8 | 2012-03-30 |
| AMICUS THERAPEUTICS, INC. (FOLD) Delisted | 10%+ Owner | 1,066,029 | $14.49 | $15.45M | $6.40M | 3 | 2012-03-09 |
| Echo Global Logistics, Inc. (ECHO) Delisted | 10%+ Owner | 4,095 | $48.24 | $197.5K | $0 | 1 | 2012-03-01 |
| VG | 10%+ Owner | 4,558,701 | $13.08 | $59.63M | $0 | 1 | 2011-03-15 |
| Financial Engines, Inc. (FNGN) Delisted | 10%+ Owner | 2,808,848 | — | — | $0 | 2 | 2010-09-01 |
| Viracta Therapeutics, Inc. (SNSS) Delisted | 10%+ Owner | — | $18.62 | — | $0 | 1 | 2009-11-03 |
| INHIBITEX, INC. (INHX) Delisted | 10%+ Owner | 1,941,407 | — | — | $3.00M | 1 | 2009-10-30 |
| Data Domain, Inc. (DDUP) Delisted | 10%+ Owner | 1,004,916 | — | — | $0 | 2 | 2009-07-10 |
| PHARMOS CORP (PARS) Delisted | Director | 2,176,488 | — | — | $0 | 7 | 2009-01-16 |
| TNDM | 10%+ Owner | 3,862,204 | $16.60 | $64.11M | $0 | 1 | 2008-09-24 |
| DZS INC. (ZHNE) Delisted | 10%+ Owner | 8,940,337 | — | — | $10.44M | 31 | 2008-03-10 |
Recent Filings · Page 3 of 13
124 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2019-02-26 | SUPN | Grant (A) | — | $0 | EDGAR |
| 2018-02-27 | SUPN | Grant (A) | — | $0 | EDGAR |
| 2017-06-15 | SUPN | Grant (A) | — | $0 | EDGAR |
| 2017-02-27 | SUPN | Grant (A) | — | $0 | EDGAR |
| 2016-03-03 | SUPN | Grant (A) | — | $0 | EDGAR |
| 2015-12-07 | SUPN | Other (J) | +33,127 | $0 | EDGAR |
| 2015-11-13 | SUPN | Other (J) | +33,159 | $0 | EDGAR |
| 2015-07-10 | Vitae Pharmaceuticals, Inc (VTAE) Delisted | Other (J) | +289 | $0 | EDGAR |
| 2015-07-02 | Vitae Pharmaceuticals, Inc (VTAE) Delisted | Other (J) | +289 | $0 | EDGAR |
| 2015-06-17 | SUPN | Other (J) | +26,012 | $0 | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.